Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579).
Kaklamani VG, Jeruss JS, Hughes E, Siziopikou K, Timms KM, Gutin A, Abkevich V, Sangale Z, Solimeno C, Brown KL, Jones J, Hartman AR, Meservey C, Jovanovic B, Helenowski I, Khan SA, Bethke K, Hansen N, Uthe R, Giordano S, Rosen S, Hoskins K, Von Roenn J, Jain S, Parini V, Gradishar W. Kaklamani VG, et al. Breast Cancer Res Treat. 2015 Jun;151(3):629-38. doi: 10.1007/s10549-015-3435-y. Epub 2015 May 26. Breast Cancer Res Treat. 2015. PMID: 26006067 Clinical Trial.
TGF-beta signaling alterations in cancer.
Bian Y, Kaklamani V, Reich J, Pasche B. Bian Y, et al. Cancer Treat Res. 2003;115:73-94. doi: 10.1007/0-306-48158-8_3. Cancer Treat Res. 2003. PMID: 12613193 Review. No abstract available.
Role of capecitabine (Xeloda) in breast cancer.
Kaklamani VG, Gradishar WJ. Kaklamani VG, et al. Expert Rev Anticancer Ther. 2003 Apr;3(2):137-44. doi: 10.1586/14737140.3.2.137. Expert Rev Anticancer Ther. 2003. PMID: 12722873 Review.
Adjuvant therapy of breast cancer.
Kaklamani VG, Gradishar WJ. Kaklamani VG, et al. Cancer Invest. 2005;23(6):548-60. doi: 10.1080/07357900500202937. Cancer Invest. 2005. PMID: 16203663 Review.
Adjuvant therapy of breast cancer.
Kaklamani VG, Gradishar WJ. Kaklamani VG, et al. Minerva Ginecol. 2005 Oct;57(5):521-36. Minerva Ginecol. 2005. PMID: 16205597 Review.
Transforming Growth Factor Beta and breast cancer.
Kaklamani V, Pasche B. Kaklamani V, et al. Cancer Treat Res. 2005;126:129-56. doi: 10.1007/0-387-24361-5_6. Cancer Treat Res. 2005. PMID: 16209065 Review. No abstract available.
Gene expression in breast cancer.
Kaklamani VG, Gradishar WJ. Kaklamani VG, et al. Curr Treat Options Oncol. 2006 Mar;7(2):123-8. doi: 10.1007/s11864-006-0047-0. Curr Treat Options Oncol. 2006. PMID: 16455023 Review.
147 results